C Diff Treatment

C Diff Treatment

1317 bookmarks
Custom sorting
Updated CDI Treatment Guidelines Change Prescribing Therapy
Updated CDI Treatment Guidelines Change Prescribing Therapy
The Infectious Diseases Society of America’s (IDSA) 2017 guideline saw an increase in using vancomycin as a first line therapy for Clostridioides difficile (CDI).
·contagionlive.com·
Updated CDI Treatment Guidelines Change Prescribing Therapy
ACHL on Twitter
ACHL on Twitter
Are you up to date on the latest antimicrobial prescribing recommendations for C. difficile? Join us with @MAD_ID_ASP for a live, one-hour virtual, symposium on October 11th. Registration is free: https://t.co/Y2yBN5TI67 #cdiff #pharmacist #antimicrobial #virtualsymposium pic.twitter.com/FTlXxQm5Ht— ACHL (@achlcme) September 27, 2021
·twitter.com·
ACHL on Twitter
Battle Superbugs on Twitter
Battle Superbugs on Twitter
RT @PeggyFund: Please save the date for our 2021 virtual FIGHT C. DIFF Gala, to be held on Monday, November 1st at 8 pm EST. More details i…
·twitter.com·
Battle Superbugs on Twitter
C DIFF FOUNDATION on Twitter
C DIFF FOUNDATION on Twitter
#Cdiff Spores and More Live Broadcast to Podcast https://t.co/tWTyXNxBdd Guest Host: Kevin Hersh Welcomed the new tool available....For #Patients #families and #caregivers https://t.co/QtVwFElCbV#microbiome #clinicaltrials #gastroenterology #Cdifficile #healthcare #CDI pic.twitter.com/xQJOCVYprd— C DIFF FOUNDATION (@cdiffFoundation) September 15, 2021
·twitter.com·
C DIFF FOUNDATION on Twitter
A budget impact analysis of bezlotoxumab versus standard of care antibiotics only in patients at high risk of CDI recurrence from a hospital management perspective in Germany
A budget impact analysis of bezlotoxumab versus standard of care antibiotics only in patients at high risk of CDI recurrence from a hospital management perspective in Germany
The study demonstrated administration of SoC + bezlotoxumab in patients at high risk of CDI recurrence is cost-saving from a hospital management perspective. Reduced length of stay in bezlotoxumab treated patients creates free spatial and personnel capacities for the treating hospital. Yet, a requir …
·pubmed.ncbi.nlm.nih.gov·
A budget impact analysis of bezlotoxumab versus standard of care antibiotics only in patients at high risk of CDI recurrence from a hospital management perspective in Germany
Living Without Fear of Clostridioides difficile | Everyday Health
Living Without Fear of Clostridioides difficile | Everyday Health
Learn about the quality-of-life challenges experienced by patients and caregivers of people affected by C. diff, and become empowered to play an active role in treatment decisions.
·everydayhealth.com·
Living Without Fear of Clostridioides difficile | Everyday Health
Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults
Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults
This clinical practice guideline is a focused update on management of Clostridioides difficile infection (CDI) in adults specifically addressing the use of fidaxomicin and bezlotoxumab for the treatment of CDI. This guideline was developed by a multidisciplinary panel representing the Infectious Dis …
·pubmed.ncbi.nlm.nih.gov·
Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults
South African Society of Clinical Microbiology Clostridioides difficile infection diagnosis, management and infection prevention and control guideline
South African Society of Clinical Microbiology Clostridioides difficile infection diagnosis, management and infection prevention and control guideline
Clostridioides difficile infection (CDI) is a problem in both developed and developing countries and is a common hospital-acquired infection. This guideline provides evidence-based practical recommendations for South Africa and other developing countries. The scope of the guideline includes C …
·pubmed.ncbi.nlm.nih.gov·
South African Society of Clinical Microbiology Clostridioides difficile infection diagnosis, management and infection prevention and control guideline
September is Sepsis Awareness Month. Many people who lose their life from a #Cdiff infection, die from sepsis. Peggy was one of those people. Knowing the signs of #sepsis while caring for someone with C. diff (or any infection), can help you save a life.
September is Sepsis Awareness Month. Many people who lose their life from a #Cdiff infection, die from sepsis. Peggy was one of those people. Knowing the signs of #sepsis while caring for someone with C. diff (or any infection), can help you save a life.
September is Sepsis Awareness Month. Many people who lose their life from a #Cdiff infection, die from sepsis. Peggy was one of those people. Knowing the signs of #sepsis while caring for someone with C. diff (or any infection), can help you save a life. #SepsisAwarenessMonth pic.twitter.com/DMKgMBxmkj— Peggy Lillis Fund (@PeggyFund) September 1, 2021
·twitter.com·
September is Sepsis Awareness Month. Many people who lose their life from a #Cdiff infection, die from sepsis. Peggy was one of those people. Knowing the signs of #sepsis while caring for someone with C. diff (or any infection), can help you save a life.
Ebselen Not Only Inhibits Clostridioides difficile Toxins but Displays Redox-Associated Cellular Killing
Ebselen Not Only Inhibits Clostridioides difficile Toxins but Displays Redox-Associated Cellular Killing
Ebselen, a reactive organoselenium compound, was shown to inhibit toxins TcdA and TcdB by covalently binding to their cysteine protease domains. It was suggested that ebselen lacked antimicrobial activity against Clostridioides difficile. However, this perception conflicts with C. difficile having e …
·pubmed.ncbi.nlm.nih.gov·
Ebselen Not Only Inhibits Clostridioides difficile Toxins but Displays Redox-Associated Cellular Killing
Add-on interventions for the prevention of recurrent Clostridioides Difficile infection: A systematic review and network meta-analysis
Add-on interventions for the prevention of recurrent Clostridioides Difficile infection: A systematic review and network meta-analysis
Add-on treatment with oligofructose, NTCD-M3 spores, rifaximin, RBX2660, and bezlotoxumab likely reduces the risk of CDI. Evidence on probiotics and SER-109 are uncertain, thus adequately powered trials are warranted.
·pubmed.ncbi.nlm.nih.gov·
Add-on interventions for the prevention of recurrent Clostridioides Difficile infection: A systematic review and network meta-analysis